With the analysis among 480 patents, we discovered top 155 key players by total patent application. Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Roche Sequencing Solutions, Inc. are dominant in this area. They take 13.33% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 22
F. Hoffmann-La Roche Ltd.
Roche Sequencing Solutions, Inc.
California, United States
Patent: 20
Pennsylvania, United States
Patent: 19
Integrated Biotherapeutics, Inc.
Tokyo-to, Japan
Patent: 13
Nordrhein-Westfalen, Germany
Patent: 13
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 11
California, United States
Patent: 10
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 9
With the analysis among 16 patents, we discovered top 2 start-ups by total patent application.
Nordrhein-Westfalen, Germany
Patent: 13
Institut National de la Santé et de la Recherche Médicale
With the analysis among related 185 patents applied in the last 5 years. We discover 93 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Roche Sequencing Solutions, Inc., Mabwell (Shanghai) Bioscience Co., Ltd. take 24.32% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 20
Roche Sequencing Solutions, Inc.
California, United States
Patent: 14
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 11
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 9
Nordrhein-Westfalen, Germany
Patent: 6
Jilin Sheng, China
Patent: 5
Qingdao Vland Biotech Co., Ltd.
Shandong Sheng, China
Patent: 4
Qingdao Weilan Biological Group Co., Ltd.
Shandong Sheng, China
Patent: 4
F. Hoffmann-La Roche Ltd.
The Children's Medical Center Corp.
Massachusetts, United States
Patent: 4
With the analysis among related 185 patents in last 5 years, we discover 72 new entrants. Mabwell (Shanghai) Bioscience Co., Ltd., Amicus Therapeutics, Inc., Qingdao Weilan Biological Group Co., Ltd. are the most active new entrants in this area.
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 11
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 9
Qingdao Weilan Biological Group Co., Ltd.
Shandong Sheng, China
Patent: 4
Academy of Military Medical Sciences
Ubiquitide Biotechnology (Zhejiang) Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Hainan Sheng, China
Patent: 2
Shanghai Center for Disease Control and Prevention
undefined undefined
Patent: 2
New York, United States
Patent: 2
With the analysis among 244 patents, we discovered top 72 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Texas A&M University, University of Liege are dominant in this area. They take 12.70% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 11
Texas, United States
Patent: 9
Université Libre de Bruxelles
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 8
New York, United States
Patent: 7
Jilin Sheng, China
Patent: 7
Universiti Teknologi Malaysia
Consejo Superior de Investigaciones Científicas
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 4
University of Massachusetts
Massachusetts, United States
Patent: 4